Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02509842

Ligand	Ligand name	Chain	PDB	Tanimoto
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.75
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.75
NGP	NOGALAMYCIN (PROTONATED FORM)	A	1L0R	0.71
CHR	NEOCARZINOSTATIN-CHROMOPHORE	A	1O5P	0.73
CHR	NEOCARZINOSTATIN-CHROMOPHORE	A,B	1NCO	0.73
DRA	11-DEOXY-BETA-RHODOMYCIN	A,B	1XDS	0.72
MDW	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	A	2DDY	0.7
AKY		A,B,C,D	2IPI	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	215D	0.75
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	235D	0.75
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	234D	0.75
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A,B	2DES	0.75
HWG	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	A,D	1R20	0.71
GNT	(-)-GALANTHAMINE	A	1DX6	0.7
GNT	(-)-GALANTHAMINE	A	1QTI	0.7
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.7
GNT	(-)-GALANTHAMINE	A,B	1W76	0.7
GNT	(-)-GALANTHAMINE	A	1W6R	0.7
DM1	DAUNOMYCIN	A	152D	0.71
DM1	DAUNOMYCIN	A,B,C,D	1O0K	0.71
DM1	DAUNOMYCIN	A	1JO2	0.71
DM1	DAUNOMYCIN	A,B	308D	0.71
DM1	DAUNOMYCIN	A	1D33	0.71
DM1	DAUNOMYCIN	A	110D	0.71
DM1	DAUNOMYCIN	A	1D11	0.71
DM1	DAUNOMYCIN	A	427D	0.71
DM1	DAUNOMYCIN	A	2D34	0.71
DM1	DAUNOMYCIN	A	3F8F	0.71
DM1	DAUNOMYCIN	A	1D10	0.71
DM1	DAUNOMYCIN	A	1DA0	0.71
XN3	N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE	A,B	1K6P	0.77
REN	(S)-reticuline	A	3FWA	0.74
REN	(S)-reticuline	A	3D2D	0.74
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.77
L75	N-[2(R)-HYDROXY-1(S)-INDANYL]-2(R)-PHENYLMETHYL-4(S)-HYDROXY-5-[4-[2-BENZOFURANYLMETHYL]-2(S)-[TERT-BUTYLAMINOCARBONYL]-PIPERAZINYL]-PENTANEAMIDE	B	1C70	0.71
NOD	N-ETHYLHYDROXY-DOXORUBICIN	A	385D	0.73
DM6	4'-EPIDOXORUBICIN	A	1D15	0.71
DM6	4'-EPIDOXORUBICIN	A	1D54	0.71
DM6	4'-EPIDOXORUBICIN	A	1D58	0.71
DM6	4'-EPIDOXORUBICIN	A	1QDA	0.71
DM2	DOXORUBICIN	A	2DR6	0.71
DM2	DOXORUBICIN	A	1P20	0.71
DM2	DOXORUBICIN	A	1I1E	0.71
DM2	DOXORUBICIN	A	151D	0.71
DM2	DOXORUBICIN	A	1D12	0.71
DM2	DOXORUBICIN	A	1DA9	0.71
HEH	HEDAMYCIN	A	1JHI	0.7
NGU	U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN	A,B	1D22	0.74
XN2	N-[2-HYDROXY-1-INDANYL]-5-[(2-TERTIARYBUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4-HYDROXY-2-(1-PHENYLETHYL)-PENTANAMIDE	A,B	1K6V	0.77
DM9	N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN	A	482D	0.71
NOV	NOVOBIOCIN	A,B	1KIJ	0.72
NOV	NOVOBIOCIN	A,B	1S14	0.72
NOV	NOVOBIOCIN	A	1AJ6	0.72
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.73
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AL9	0.74
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AGL	0.74
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.72
AKA	10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA)	A	1Q0Z	0.72
NCS		B	1KVH	0.72
NCS		A	2NEO	0.72
CX6	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	A,B,C,D,E,F	2AL4	0.73
BNR	BIS-DAUNORUBICIN	B	1AMD	0.73
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.71
MNG	MENOGARIL	A,B	202D	0.76
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1E1Y	0.71
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A,B	3BLR	0.71
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1C8K	0.71
HMT	(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine	0,1,2,3,9,A,B,C,F,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G6E	0.74
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1D36	0.7
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1R68	0.7
MAR	4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN	A	1D35	0.7
CMD	3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)-DOXORUBICIN	A	236D	0.73
OXI	OXOLINIC ACID	A,B	1KSE	0.71
DM3	6-DEOXYDAUNOMYCIN	A	1D14	0.72
EH5	N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]-[2-(HEXAHYDRO-BENZO[1,3]DIOXOL-5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)-4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE	A	1LF3	0.73
GL8	GALANTHAMINE DERIVATIVE	A	1W4L	0.7
S2A		A	2OEY	0.71
AKT	10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT)	A	1Q0R	0.74
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.79
NCG		A	1MP7	0.7
NGM	NOGALAMYCIN	A,B,C,D	258D	0.74
NGM	NOGALAMYCIN	A	282D	0.74
NGM	NOGALAMYCIN	A,B	224D	0.74
NGM	NOGALAMYCIN	A,B	245D	0.74
NGM	NOGALAMYCIN	A,B	1QCH	0.74
NGM	NOGALAMYCIN	A	1D17	0.74
NGM	NOGALAMYCIN	A,B	1D21	0.74
NGM	NOGALAMYCIN	A,B	182D	0.74